home · filing · 0001193125-23-172678
8-K filed June 22, 2023, 7:59 PM ET
ticker TSHA
CIK 0001806310
leadership
confidence high
sentiment neutral
materiality 0.30
Taysha regains Nasdaq independence compliance; Manning resigns, Stalfort appointed
Taysha Gene Therapies, Inc.
Paul Manning resigned from board effective June 20, 2023 to enable compliance with Nasdaq Rule 5605(b)(1); remains as non-voting observer.
Sean Stalfort appointed as independent Class I director, chair of Nominating/Governance Committee, and member of Compensation Committee.
Stalfort granted option for 43,800 shares at closing price, vesting over 36 months; annual retainer $35k plus committee fees.
Majority of board now independent; company has regained compliance with Nasdaq listing requirements.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-06-21
Successor Paul B. Manning
Filed June 22, 2023, 7:59 PM ET
on June 21, 2023, the Board appointed Sean Stalfort to serve as a director of the Company, effective immediately following Mr. Manning’s resignation
Effective 2023-06-20
Successor Sean Stalfort
Filed June 22, 2023, 7:59 PM ET
on June 20, 2023, Paul B. Manning provided notice to the Board of his decision to resign from the Board and all committees thereof
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sean Stalfort was appointed as director at Taysha Gene Therapies, Inc..
Action appointed
Role director
Exact text from the filing
on June 21, 2023, the Board appointed Sean Stalfort to serve as a director of the Company, effective immediately following Mr. Manning’s resignation
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul B. Manning resigned as director at Taysha Gene Therapies, Inc..
Action resigned
Role director
Exact text from the filing
on June 20, 2023, Paul B. Manning provided notice to the Board of his decision to resign from the Board and all committees thereof
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-23-172678
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.